Detecting the Rest Tremor Associated With Parkinson's Disease Using Analysis of the Muscle Contractions Rhythmicity

NCT ID: NCT05998486

Last Updated: 2023-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-03

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Resting tremors associated with Parkinson's disease (PD) remains difficult to quantify and track during disease progression. This study propose to explore the rhythmicity of distal muscle contractions in the upper limb to characterize resting tremor and discriminate it from cerebellar tremor (CT) based on the frequency spectrum of the EMG signal.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This retrospective study analyzed surface EMG recordings of wrist flexor-pronators and extensor-supinators from patients with PD or CT bilaterally in five 10-second conditions: rest with contralateral motor distraction, symmetrical arms extended forward posture with hands pronated, semi-pronation, supination, and elbows flexed with hands pronated. The rhythmicity index (RI) is calculated from the ratio of the area of the maximum power peak to the total area of the spectrum between 1.5-12Hz.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Cerebellar Tumor Rest Tremor Diagnoses Disease Movement; Abnormal, Involuntary

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tremor of rest

Patient with a diagnosis of Parkinson's disease and who performed surface EMG recordings of wrist flexor-pronators and extensor-supinators analysis in Laboratories

EMG in wrist flexor-pronators and extensor-supinators

Intervention Type DIAGNOSTIC_TEST

The subject is asked to perform a series of tasks: resting posture, symmetrical posture arms forward, unilateral distal movement. Each task lasts 10 seconds.

Cerebellar tremor

Patient with a diagnosis of cerebellar tremor and who performed surface EMG recordings of wrist flexor-pronators and extensor-supinators analysis in Laboratories

EMG in wrist flexor-pronators and extensor-supinators

Intervention Type DIAGNOSTIC_TEST

The subject is asked to perform a series of tasks: resting posture, symmetrical posture arms forward, unilateral distal movement. Each task lasts 10 seconds.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EMG in wrist flexor-pronators and extensor-supinators

The subject is asked to perform a series of tasks: resting posture, symmetrical posture arms forward, unilateral distal movement. Each task lasts 10 seconds.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patient who performed surface EMG recordings of wrist flexor-pronators and extensor-supinators in Laboratories;
* diagnosis of Parkinson's disease or cerebellar tremor.

Exclusion Criteria

* Botulinium toxin injection in upper limb during a delay of 3 months before surface EMG recordings;
* Levodopa drugs administrated during a delay of 12 hours before surface EMG recordings;
* Tremor-favour drugs administrated during a delay of 30 days before surface EMG recordings;
* Presence of an other neurologic disease or of any disease associated with motor disorders in upper limb.
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Henri Mondor University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emilie Hutin

Co-director of laboratory

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emilie Hutin

Role: PRINCIPAL_INVESTIGATOR

Henri Mondor University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Laboratoire Analyse et Restauration du Mouvement

Créteil, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Emilie Hutin, PhD

Role: CONTACT

+33149812549

Emilie Hutin

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Emilie Hutin, PhD

Role: primary

+33149812549

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ARM-Tremor

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Brain Anatomy in Dystonia
NCT00031369 TERMINATED